BTMD Stock Analysis: Buy, Sell, or Hold?
BTMD - Biote Corp. Class A Common Stock
$1.97
0.02 (1.03%)
▲
5d:
-9.63%
30d:
-6.19%
90d:
-7.51%
HOLD
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Get Alerted When BTMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BTMD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: BTMD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$3.08
Based on 12.7% avg growth
INTRINSIC VALUE TODAY
$1.91
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 3.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BTMD is currently trading at $1.97, which is considered fair relative to its 30-day fair value range of $1.78 to $2.29. From a valuation perspective, the stock is trading at a premium (Forward PE: 3.4) compared to its historical average (3.0). At these levels, the market is pricing in 4.9% annual earnings growth.
Technical Outlook: Technically, BTMD is in a downtrend. Immediate support is located at $1.90, while resistance sits at $2.29.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.99 (+53.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BTMD is in a downtrend. Immediate support is located at $1.90, while resistance sits at $2.29.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.99 (+53.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.78 -
$2.29
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
75.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 53.1% below Wall St target ($2.99)
- BULLISH: Expecting earnings turnaround to 4.9% growth with -8.3% revenue growth
- CAUTION: Recommendation downgraded due to -9.6% 5-day decline
Trading Range Analysis
30-Day Trading Range
$1.78 -
$2.29
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.90
Resistance Level
$2.29
Current Trend
Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
3.42
Wall Street Target
$2.99
(+53.1%)
Revenue Growth (YoY)
-8.3%
Earnings Growth (YoY)
-83.8%
Profit Margin
8.3%
Valuation Premium vs History
+4.9% premium
PE vs Historical
3.4 vs 3.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.9%
(market-implied from PE analysis)
1-Year Target
$2.05
(+5%)
2-Year Target
$2.15
(+10%)
3-Year Target
$2.25
(+15%)
3-Yr Target (if PE normalizes)
(PE: 3→3)
PE COMPRESSION
$1.97
(+1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 21.3%)
$22.41
(+1049%)
Base:
(SPY PE: 3.4, Growth: 21.3%)
$3.48
(+78%)
Bear:
(PE: 2.9, Growth: 21.3%)
$2.96
(+52%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (5x PE), but valuation improves significantly next year (3x PE) as earnings recover.
Trailing PE: 4.72 | Current EPS (TTM): $0.43
Bull Case
$2.96
(+52%)
Analyst growth 32.6%, PE expands to 5.2
Base Case
$2.69
(+38%)
Market implied 32.6%, PE stable at 4.7
Bear Case
$1.38
(-29%)
Severe decline -20.0%, PE contracts to 4.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: May 15, 2026 4:10 PM ET
Data refreshes hourly during market hours. Next update: 5:10 PM
Data refreshes hourly during market hours. Next update: 5:10 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BTMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$513 | 64 BUY |
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$246 | 61 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 61 BUY |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$21 | 59 HOLD |
|
OPCH
Option Care Health Inc |
STRONG BUY
10 analysts |
$29 | 59 HOLD |
